Loading companies…
CT
City Therapeutics
United States · Biotech · Healthtech · Enterprise software
Develops next-generation RNAi therapeutics and engineering platform for multiple disease areas
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | $99.5M | AN Ventures — Role not disclosedARCH Venture Partners — Role not disclosedCasdin Capital — Role not disclosedFidelity Management & Research Company — Role not disclosedInvus — Role not disclosedNYBC Ventures — Role not disclosedRegeneron Ventures — Role not disclosedRock Springs Capital — Role not disclosedSlate Path Capital — Role not disclosedSofinnova Investments — Role not disclosedViking Global Investors — Role not disclosed |
Investors
AN VenturesSeries BARCH Venture PartnersSeries BCasdin CapitalSeries BFidelity Management & Research CompanySeries BInvusSeries BNYBC VenturesSeries BRegeneron VenturesSeries BRock Springs CapitalSeries BSlate Path CapitalSeries BSofinnova InvestmentsSeries BViking Global InvestorsSeries BCoverage
Jun 8, 2026City Therapeutics · Series BSimilar companies
GMGeneral MedicineAn online healthcare store where people compare care options and upfront prices, book visits and order medications or lab tests.$120M · Series B
AAligatorAI media intelligence for PR and marketing teams to monitor brand coverage, understand audience and competitor sentiment, and spot reputational risks across channels and languages.$1.2M · Seed
